Chester County News and Community Website
WAYNE, PA — Teleflex Incorporated (NYSE: TFX) has announced findings from a new multinational study demonstrating the efficacy of its Arrow™ Chlorhexidine-Impregnated Central Venous Catheters (CVCs) in reducing central line-associated …
Teleflex Study Shows 70.5% Reduction in CLABSI with Antimicrobial CVCs Read More WAYNE, PA — Teleflex Incorporated (NYSE: TFX) has introduced two major initiatives during Men’s Health Month to highlight the challenges men face with benign prostatic hyperplasia (BPH) and the importance …
Teleflex Launches Awareness Initiatives for Men’s Health Month Read More
PHILADELPHIA, PA — Dr. Asif Ilyas, a distinguished surgeon with Rothman Orthopaedics in Philadelphia, has been named to the 2025 Orthopedic Surgery Research All Stars, placing him among the top …
Dr. Asif Ilyas Named to Orthopedic Surgery Research All Stars Top 3% Nationwide by Avant-Garde Health Read More
WILMINGTON, DE — The Phase III DESTINY-Breast09 clinical trial has delivered groundbreaking results, demonstrating that ENHERTU® (fam-trastuzumab deruxtecan-nxki) plus pertuzumab significantly improves progression-free survival (PFS) for patients with HER2-positive metastatic …
ENHERTU plus Pertuzumab Shows Significant Progress in First-Line Treatment for HER2-Positive Breast Cancer Read More
WASHINGTON, D.C. — The Centers for Disease Control and Prevention (CDC) has issued a warning regarding a multistate outbreak of Salmonella infections linked to recalled eggs sold across nine states. …
Urgent CDC Warning: Recalled Eggs Linked to Salmonella Outbreak – Are You at Risk? Read More
MALVERN, PA — TELA Bio, Inc. (NASDAQ: TELA) has announced the European launch of its OviTex Inguinal Reinforced Tissue Matrix, the first reinforced tissue matrix explicitly designed for laparoscopic and …
TELA Bio Launches OviTex Reinforced Tissue Matrix for Hernia Repair in Europe Read More WILMINGTON, DE — The Phase III MATTERHORN trial has delivered groundbreaking results, demonstrating that AstraZeneca’s IMFINZI® (durvalumab) combined with FLOT chemotherapy significantly improves outcomes for patients with resectable early-stage and …
MATTERHORN Trial Reveals Promising Results for Early Gastric Cancer Treatment Read More WILMINGTON, DE — Groundbreaking results from AstraZeneca’s Phase III SERENA-6 trial reveal a significant leap forward in the treatment of hormone receptor (HR)-positive, HER2-negative advanced breast cancer. The trial demonstrated …
AstraZeneca’s SERENA-6 Trial Marks Breakthrough in Breast Cancer Treatment Read MoreWAYNE, PA — Aclaris Therapeutics, Inc. (NASDAQ: ACRS) has announced the initiation of a Phase 2 trial for its investigational drug bosakitug (ATI-045), targeting moderate-to-severe atopic dermatitis (AD). This randomized, …
Aclaris Therapeutics Launches Phase 2 Trial for Promising Atopic Dermatitis Treatment Read More
WASHINGTON, D.C. — The Centers for Medicare & Medicaid Services (CMS) has issued a pointed warning to select hospitals performing pediatric sex trait modification procedures, citing significant concerns over the …
CMS Exposes Risks of Pediatric Gender Procedures – Demands Immediate Action from Hospitals Read More